Bank of New York Mellon’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$27.3M Buy
1,499,316
+30,707
+2% +$559K 0.01% 1351
2025
Q1
$29.1M Sell
1,468,609
-52,557
-3% -$1.04M 0.01% 1291
2024
Q4
$26.1M Buy
1,521,166
+147,748
+11% +$2.53M ﹤0.01% 1407
2024
Q3
$27.5M Buy
1,373,418
+606,874
+79% +$12.1M 0.01% 1400
2024
Q2
$8.57M Buy
766,544
+49,631
+7% +$555K ﹤0.01% 2039
2024
Q1
$4.73M Sell
716,913
-62,989
-8% -$416K ﹤0.01% 2354
2023
Q4
$3.53M Sell
779,902
-25,798
-3% -$117K ﹤0.01% 2541
2023
Q3
$2.88M Buy
805,700
+16,551
+2% +$59.3K ﹤0.01% 2595
2023
Q2
$2.91M Buy
789,149
+113,341
+17% +$418K ﹤0.01% 2624
2023
Q1
$2.24M Buy
675,808
+27,928
+4% +$92.4K ﹤0.01% 2739
2022
Q4
$2.51M Buy
647,880
+67,053
+12% +$260K ﹤0.01% 2723
2022
Q3
$1.41M Buy
580,827
+81,017
+16% +$197K ﹤0.01% 3037
2022
Q2
$990K Buy
499,810
+416,409
+499% +$825K ﹤0.01% 3216
2022
Q1
$153K Buy
83,401
+36,967
+80% +$67.8K ﹤0.01% 4312
2021
Q4
$65K Hold
46,434
﹤0.01% 4460
2021
Q3
$52K Sell
46,434
-13,316
-22% -$14.9K ﹤0.01% 4425
2021
Q2
$96K Sell
59,750
-145,662
-71% -$234K ﹤0.01% 4218
2021
Q1
$362K Sell
205,412
-3,363
-2% -$5.93K ﹤0.01% 3837
2020
Q4
$406K Buy
208,775
+14,953
+8% +$29.1K ﹤0.01% 3714
2020
Q3
$463K Sell
193,822
-23,015
-11% -$55K ﹤0.01% 3527
2020
Q2
$635K Buy
216,837
+23,183
+12% +$67.9K ﹤0.01% 3354
2020
Q1
$558K Buy
193,654
+32,001
+20% +$92.2K ﹤0.01% 3304
2019
Q4
$647K Buy
161,653
+27,901
+21% +$112K ﹤0.01% 3456
2019
Q3
$595K Buy
133,752
+51,576
+63% +$229K ﹤0.01% 3436
2019
Q2
$317K Buy
82,176
+21,545
+36% +$83.1K ﹤0.01% 3787
2019
Q1
$230K Buy
60,631
+5,803
+11% +$22K ﹤0.01% 3829
2018
Q4
$131K Hold
54,828
﹤0.01% 3920
2018
Q3
$340K Hold
54,828
﹤0.01% 3782
2018
Q2
$247K Buy
54,828
+35,791
+188% +$161K ﹤0.01% 3870
2018
Q1
$87K Buy
+19,037
New +$87K ﹤0.01% 4074
2017
Q4
Sell
-21,344
Closed -$66K 4337
2017
Q3
$66K Hold
21,344
﹤0.01% 4058
2017
Q2
$79K Buy
+21,344
New +$79K ﹤0.01% 4065